Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.

Laura AdubraDagmar AlberPer AshornUlla AshornYin Bun CheungElaine Cloutman-GreenFatoumata DialloCamilla DuckerRiku ElovainioYue-Mei FanLily GatesGwydion GruffuddTiia HaapaniemiFadima HaidaraLotta HallamaaRikhard IhamuotilaNigel KleinJuho LuomaOwen MartellSamba SowTaru Vehmastonull null

Published in: Trials (2023)

ClinicalTrials.gov NCT04424511. Registered on 11 June 2020.

Keyphrases

drug administration
double blind
placebo controlled
clinical trial
phase ii
phase iii
study protocol
cardiovascular events
phase ii study
open label
risk factors
randomized controlled trial
type diabetes
coronary artery disease
squamous cell carcinoma